Skip to main content
Equibles

HRT FINANCIAL LP

Position in XGN — Exagen Inc.

CIK 1475597 NEW YORK, NY
Back to XGN Full portfolio

Position in XGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$74,851
-$349,077 QoQ
Shares Held
16,097
-76.9% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 57 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $274,130,834 across 19 Diagnostics & Research names. XGN ranks #17 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GH
Guardant Health, Inc.
 703,915 $105,608,367
2 NTRA
Natera, Inc.
 125,379 $34,034,129
3 ILMN
Illumina, Inc.
 137,982 $24,261,375
4 IDXX
Idexx Laboratories Inc /De
 37,575 $19,780,983
5 SHC
Sotera Health Co
 1,111,462 $19,728,450
6 MEDP
Medpace Holdings, Inc.
 34,527 $18,285,153
7 PSNL
Personalis, Inc.
 930,816 $12,472,934
8 BLLN
BillionToOne, Inc.
 80,709 $9,683,465

All Filings in XGN

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $74,851 16,097
2025-12-31 $423,928 69,725